Overview

A Study for Post op Inflammation After Cataract Surgery

Status:
Enrolling by invitation
Trial end date:
2023-05-15
Target enrollment:
Participant gender:
Summary
This is a randomized, controlled study to assess the safety and effectiveness of treatment with an intracanalicular dexamethasone (0.4mg) insert when utilized in conjunction with topical steroids as part of an extended taper steroid regimen following cataract surgery in patients with a history of epiretinal membrane, diabetic retinopathy, or non-exudative macular degeneration.
Phase:
Phase 4
Details
Lead Sponsor:
Wyse Eyecare
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate